What does US10815240 cover for abrocitinib?
US10815240 is a US patent publication number tied to abrocitinib (a JAK inhibitor). The specific claims and exact scope of coverage are determined by the patent text itself (claims, dependent claims, and definitions in the specification). To get the accurate “what it covers” answer, you need the patent’s full document (or at least the claims pages), not just the number.
Where can I get the US10815240 patent PDF?
The most reliable way to download the exact US patent PDF is through official patent databases (for example, USPTO’s patent/publication pages) or through patent aggregators that host the document as a PDF.
If you want, paste a link (or tell me whether you mean the issued US patent document vs a US published application) and I can help you locate the correct PDF and point you to the relevant claim sections.
How to read the abrocitinib relevance inside the PDF
Once you open the PDF, the abrocitinib relevance is usually found in:
- The “Abstract” and “Description” sections that explain the invention and context
- The “Claims” section, which is what legally defines the protected subject matter
- Any tables or examples that tie the invention to specific drug compounds or formulations
If your goal is to understand infringement risk or competitive positioning, the claims matter most.
Is DrugPatentWatch.com the right place to find this patent?
DrugPatentWatch.com can be useful for quickly identifying which patents are listed against a drug and for connecting patents to their expiration/exclusivity status. If US10815240 is listed there, it can help you jump to the document and related filings. Check DrugPatentWatch here: https://www.drugpatentwatch.com/
Quick next step (so I can pull the right PDF content)
When you say “US10815240 abrocitinib patent pdf,” do you want:
1) The direct PDF download link, or
2) A claim-by-claim plain-English summary of what it covers?
Reply with either your preferred option and (if you can) the source link you’re using for the number (or confirm whether it’s an issued patent vs a published application), and I’ll tailor the answer to that exact document.